BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group.

Hualei BuJingying ChenQingshui LiJianqing HouYuan WeiXiaohang YangYana MaHongsheng HeYouzhong ZhangBeihua Kong

Published in: The journal of obstetrics and gynaecology research (2019)

BRCA1/2 mutation prevalence in Chinese ovarian cancer patients is higher than the international rate. We recommend BRCA1/2 testing for patients with family histories and personal histories of malignancy and genetic counseling for cancer in healthy people with high-risk family histories.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
squamous cell carcinoma
peritoneal dialysis
dna methylation
patient reported outcomes
human immunodeficiency virus
patient reported
young adults
hiv infected
men who have sex with men